SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-026376
Filing Date
2022-09-20
Accepted
2022-09-20 16:30:30
Documents
20
Period of Report
2022-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 127509
2 ex2-1.htm EX-2.1 1001047
3 ex10-1.htm EX-10.1 102328
4 ex10-2.htm EX-10.2 91528
5 ex10-3.htm EX-10.3 99548
6 ex10-4.htm EX-10.4 176453
7 ex99-1.htm EX-99.1 30083
8 ex99-1_001.jpg GRAPHIC 4028
  Complete submission text file 0001493152-22-026376.txt   2141260

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT foxw-20220916.xsd EX-101.SCH 4457
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT foxw-20220916_def.xml EX-101.DEF 27861
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT foxw-20220916_lab.xml EX-101.LAB 38814
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT foxw-20220916_pre.xml EX-101.PRE 26478
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7585
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39891 | Film No.: 221254039
SIC: 2834 Pharmaceutical Preparations